Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis

PURPOSE OF REVIEW: Dual antiplatelet therapy (DAPT)—aspirin in conjunction with a P2Y(12) inhibitor—is the cornerstone of managing patients with acute coronary syndromes post-revascularization, but the clinical response is highly variable, with potentially devastating consequences. Herein, we review...

Descripción completa

Detalles Bibliográficos
Autores principales: Shpigelman, Jonathan, Proshkina, Anastasia, Daly, Michael J., Cox, Dermot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Cardiovascular Genomics (KG Aragam, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307718/
https://www.ncbi.nlm.nih.gov/pubmed/37261665
http://dx.doi.org/10.1007/s11886-023-01892-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307718/
https://www.ncbi.nlm.nih.gov/pubmed/37261665
http://dx.doi.org/10.1007/s11886-023-01892-9

Ejemplares similares